These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11712177)

  • 41. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
    Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
    Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of fibrin monomer on spontaneous platelet aggregation].
    Levin GIa; Egorikhina MN; Taranenko IA; Momot AP
    Klin Lab Diagn; 2011 Mar; (3):39-42. PubMed ID: 21584967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Covalent structure of single-stranded fibrin oligomers cross-linked by FXIIIa.
    Rosenfeld MA; Leonova VB; Shchegolikhin AN; Bychkova AV; Kostanova EA; Biryukova MI
    Biochem Biophys Res Commun; 2015 May; 461(2):408-12. PubMed ID: 25896761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor.
    Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
    Thromb Res; 1986 Dec; 44(5):611-23. PubMed ID: 3810563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A three-dimensional consideration of variant human fibrinogens.
    Everse SJ; Spraggon G; Doolittle RF
    Thromb Haemost; 1998 Jul; 80(1):1-9. PubMed ID: 9684777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters.
    Vaudaux P; Pittet D; Haeberli A; Lerch PG; Morgenthaler JJ; Proctor RA; Waldvogel FA; Lew DP
    J Infect Dis; 1993 Mar; 167(3):633-41. PubMed ID: 8440934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain.
    Errasti ME; Prospitti A; Viana CA; Gonzalez MM; Ramos MV; Rotelli AE; Caffini NO
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):441-9. PubMed ID: 26886361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cleavage sequence of fibrinopeptide A from fibrinogen fragment E by thrombin, atroxin or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):107-12. PubMed ID: 8457636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural difference between polymerized and non-polymerized fragment X, obtained by plasmin digest of fibrinogen.
    Sato H; Swadesh JK
    Int J Biol Macromol; 1993 Dec; 15(6):323-7. PubMed ID: 8110652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinction between fibrinogen and fibrin degradation products in plasma.
    Gaffney PJ
    Clin Chim Acta; 1975 Nov; 65(1):109-15. PubMed ID: 1192601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The antiplasmin activity of the E fragments of fibrin and fibrinogen].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1990; (4):511-8. PubMed ID: 2148755
    [No Abstract]   [Full Text] [Related]  

  • 54. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
    Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of coaggregation between Porphyromonas gingivalis and Streptococcus oralis by fibrinogen fragments.
    Nagata H; Amano A; Hanioka T; Tamagawa H; Shizukuishi S; Miyata T
    FEMS Microbiol Lett; 1993 Nov; 114(1):31-6. PubMed ID: 8293957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of thermostable structure from the fibrinogen D fragment.
    Medved' LV; Privalov PL; Ugarova TP
    FEBS Lett; 1982 Sep; 146(2):339-42. PubMed ID: 7140981
    [No Abstract]   [Full Text] [Related]  

  • 57. Altered immunoelectrophoretic profiles of fibrinogen in full-term newborns.
    Kordich L; Bergonzelli G; Lago O; Sassetti B; Porterie P
    Thromb Res; 1986 Dec; 44(5):695-700. PubMed ID: 3810568
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanism of aggregation of fibrinogen molecules: the influence of fibrin-stabilising factor.
    Rozenfel'd MA; Vasil'eva MV
    Biomed Sci; 1991; 2(2):155-61. PubMed ID: 1685332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for age-related differences in human fibrinogen.
    Ignjatovic V; Ilhan A; Monagle P
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):110-7. PubMed ID: 21192254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Theme issue: fibrinogen and fibrin--structure, function, interactions and clinical applications.
    Dempfle CE; Mosesson MW
    Thromb Haemost; 2003 Apr; 89(4):599-600. PubMed ID: 12669112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.